ucb sa (UCB:Euronext Brussels)
Transactions by UCB SA (UCB) in the last 6 months
Advent International Corporation and Avista Capital Holdings, L.P. signed an agreement to acquire Kremers Urban Pharmaceuticals Inc. from UCB SA (ENXTBR:UCB) for $1.5 billion in cash on November 7, 2014. The deal financing is provided by Credit Suisse Securities LLC, Morgan Stanley & Co. LLC, Goldman, Sachs & Co and Jefferies LLC. Brian Markison, a healthcare Industry Executive at Avista, will become President and Chief Executive Officer of Kremers Urban. The transaction ...
Avista Capital Holdings, L.P.
Dermira, Inc. (NasdaqGS:DERM) announced that it has entered into a common stock purchase agreement for the private placement of 468,750 shares at a price of $16 per share for gross proceeds of $7,500,000 on September 19, 2014.The company will not pay any underwriting discounts or commissions with respect to the shares. The securities will be issued to the existing investor UCB SA. The investor invested through its affiliate, UCB Pharma S.A.
Dermira Inc. announced a private placement of 30,722,886 shares of series C convertible preferred stock at $1.66 per share for gross proceeds of $50,999,990.76 on August 15, 2014. The preferred stock issued in the transaction has a par value of $0.001 per share. The company announced that each share of preferred stock is convertible into one share of common stock of the company at a price of $1.66 per share and holds a dividend payment of $0.13 per share per annum. The ...
Apple Tree Partners
Bay City Capital LLC
Fidelity Advisor Series VII - Fidelity Advisor Biotechnology Fund
New Enterprise Associates
Rock Springs Capital
|Endo International PLC||$81.11 USD||-0.53|
|Grifols SA||€37.40 EUR||+0.16|
|Hospira Inc||$64.28 USD||-0.50|
|Sigma-Aldrich Corp||$137.34 USD||-0.31|
|Valspar Corp/The||$83.87 USD||+0.09|
|View Industry Companies|